Publications
Résultats 371 à 380 sur 563 Publications
| Titre | Auteurs | Année | Revue |
|---|---|---|---|
| Digital tools for delivery of dementia education for caregivers of persons with dementia: A systematic review and meta-analysis of impact on caregiver distress and depressive symptoms | Scerbe, A.**, O'Connell, M. E.*, Astell, A.*, Morgan, D.*, Kosteniuk, J.*, Panyavin, I., DesRoches, A., & Webster, C. | 2023 | PLoS One |
| Diffusion tensor tractography of the fornix in cerebral amyloid angiopathy, mild cognitive impairment and Alzheimer’s disease | Shaikh I., Beaulieu C.*, Gee M., McCreary C.R., Beaudin A.E.**, Valdés-Cabrera D., Smith E.E.*, Camicioli R.* | 2022 | NeuroImage: Clinical |
| Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation | Dadar, M.**, Mahmoud, S., Narayanan, S.*, Collins, L. D.*, Arnold, D. L., & Maranzano, J.* | 2021 | Brain: A Journal of Neurology |
| Diffusely abnormal white matter converts to T2 lesion volume in the absence of acute inflammation | Dadar M**, Mahmoud S, Narayanan S*, Collins DL*, Arnold DL, Maranzano J* | 2021 | bioRxiv |
| Differential Effects of Chronic Immunosuppression on Behavioral, Epigenetic and Alzheimer’s DiseaseAssociated Markers in 3xTg-AD Mice | Kapadia M, Mian FM, Ma D, Hutton CP, Azam A, Narkaj K, Cao C, Brown B, Michalski B, Morgan D, Forsythe P, Zovkic IB, Fahnestock M*, Sakic B. | 2020 | Alzheimer's Research & Therapy |
| Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer’s disease | Iulita, M. F., Bistue Millon, M. B., Pentz, R., Aguilar, L. F., Do Carmo, S., Allard, S., Michalski, B., Wilson, E. N., Ducatenzeiler, A., Bruno, M. A., Fahnestock, M., & Cuello, A. C. | 2017 | Neurobiology of Disease |
| Differential Cognitive Decline in Alzheimer’s Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure | Sapkota, S., McFall, G. P.*, Masellis, M.*, Dixon, R. A.*, & Black, S. E.* | 2022 | Journal of Alzheimer's disease |
| Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum | Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier FZ, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P*, Blennow K, Suárez-Calvet M, for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort | 2021 | JAMA Neurology |
| Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative | Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Moscoso Rial A, Pascoal TA, Andreasson U, Scholl M, Weiner H, Rosa-Neto P*, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H, for the Alzheimer's Disease Neuroimaging Initiative | 2020 | Molecular Psychiatry |
| Developing the Driving Cessation in Dementia Toolkit (DCDT): A Knowledge-to-Action Process | Naglie G*, Stasiulis E, Sanfors S, Bédard M*, Belchior P*, Byzewski A*, Crizzle A*, Gélinas I*, Marshall S*, Mazer B*, Molnar F*, Moorhouse P*, Myers A, Polgar J, Porter M*, Tuokko H, Vrkljan B*, Yamin S*, Rappoport M* on behalt of the CCNA Driving Cessation Team | 2020 | CGS Book of Abstracts |
Résultats 371 à 380 sur 563 Publications